PLAINS GP HOLDINGS LP (PAGP): what the price assumes

boothcheck covers PLAINS GP HOLDINGS LP (PAGP) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-08-08.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/PAGP

Headline

FieldValue
TickerPAGP
CompanyPLAINS GP HOLDINGS LP
Sector / IndustryEnergy
Current price$28.02/sh
CompositionCrude Oil - Sales 96% / Crude Oil - Transportation 3% / Crude Oil - Terminalling, Storage and Other 1% / NGL - Sales 0% / NGL - Terminalling, Storage and Other 0% / Other revenues 0% / Intersegment revenues elimination 0%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)2.8%
Operating margin today3.1%
Margin compression (value-band)-0.3pp
Multiple paid6x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 5.8% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.39σ
cohort percentile (of 48 peers)10

Valuation X-Ray

The price is supported by earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0
Earnings0.46x4justifies
Relative0.55x2justifies
Growth0.26x3justifies

Families that justify the price: Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$342.510.08xyesFCF base $2.5B, growth 14% (input: historical growth), terminal g 4.0%, WACC 9.0%, 6yr projection
DCF Exit MultipleGrowth$107.330.26xyesExit EV/EBITDA: 4.0x / 1.8x / 3.8x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelativenoP/E 18x (static sector reference · 2026-04), scenarios: 14.8x / 18.0x / 21.2x (bear / base = reference held flat / bull), EV/EBITDA 7.93x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAssetno
Two-Stage Excess ReturnAssetno
Discounted Future Market CapGrowth$26.981.04xyesRev $52.3B, growth 14% (input: historical growth; tapered), Terminal P/S: 0.1x / 0.1x / 0.1x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$33.590.83xyesEPS $2.80, growth 2% (input: historical EPS growth), PEG=5.00 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$45.970.61xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.24B × (1−40%) / WACC 9.0% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $2.58B × sector EV/EBITDA 12.0x
FCF YieldEarnings$133.800.21xyesFCF $2370.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$90.330.31xyesEPS $2.80 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativenoRevenue $52.31B × sector P/S 2.5x
PEG Fair ValueRelative$104.980.27xyesEPS $2.80 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$30.260.93xyesEPS $2.80 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Crude Oiloperatingenterprise$44.1bwithheldunresolved no unit value
NGLoperatingenterprise$151.0mwithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$7.5b
Net debt / NOPAT (after-tax)10.30x
Net debt / operating income (pre-tax)4.56x
Interest coverage3.1x
Burning cashno

Peer Cohorts (Per Segment, With Filing Citations)

Crude Oil (reported)

NGL (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive PAGP report on boothcheck